SLU-PP-332 Chemical Profile Research shows slu pp functions as a synthetic REV-ERB agonist with high selectivity for REV-ERB and REV-ERB receptors
Dihydroberberine (DHB) is a metabolite of berberine thats naturally formed in the gut and absorbed more easily (5x more than standard berberine) due to its reduced, more lipophilic structure, though it currently has less extensive clinical validation despite promising preliminary research
F2,6BP is a potent allosteric activator of the rate limiting enzyme of glycolysis, PFK-1, and an inhibitor of the gluconeogenic enzyme, fructose-1,6-bisphosphatase
and Innoveix Pharmaceuticals Inc
What we should not do is take a wait-and-see position, hoping that research groups will come along to propose and scrape together funding for long-term trials that may not give us actionable results before 2030